Excretion balance, pharmacokinetics and metabolism of S44819 after single administration of [14C]-S44819 in young healthy male volunteers. A phase 1 monocentre open-label study.
Completed
- Conditions
- stroke10029305
- Registration Number
- NL-OMON44446
- Lead Sponsor
- Institut de Recherches Internationales Servier (I.R.I.S.)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 4
Inclusion Criteria
- healthy male caucasian participants aged between 18-45 years inclusively
- 18.5 kg/m²*BMI* 30.0 kg/m²
- Body weight * 50 kg
- Be a non-smoker (or having not smoked for at least 6 months prior to the selection visit)
Exclusion Criteria
Suffering from hepatitis B, hepatitis C, cancer or HIV/AIDS. In case of participation in another drug study within 90 days before the start of this study. Donation of blood derivates or loss of more than 50 mL of blood within the 90 days before the day of selection, during the study and 3 months following completion of the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method